Alnylam Pharmaceuticals
(ALNY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -82,824 | -65,935 | -440,242 | -302,372 | -450,125 |
| Depreciation Amortization | 28,520 | 13,517 | 54,054 | 73,058 | 49,526 |
| Income taxes - deferred | 794 | 454 | -713 | N/A | N/A |
| Accounts receivable | 10,050 | 410 | -87,939 | -91,808 | 16,183 |
| Accounts payable and accrued liabilities | 69,605 | -4,865 | 80,840 | 119,506 | 766 |
| Other Working Capital | -146,810 | -108,458 | 57,261 | 3,967 | -21,559 |
| Other Operating Activity | 163,308 | 83,362 | 440,895 | 331,600 | 179,748 |
| Operating Cash Flow | $42,643 | $-81,515 | $104,156 | $133,951 | $-225,461 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,689 | -54,647 | -269,701 | -44,354 | -55,120 |
| PPE Investments | -20,991 | -12,973 | -62,211 | -46,902 | -29,810 |
| Other Investing Activity | 0 | 0 | -4,438 | -4,438 | 0 |
| Investing Cash Flow | $-33,680 | $-67,620 | $-336,350 | $-95,694 | $-84,930 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 158,637 | 25,859 | 147,464 | 116,570 | 91,765 |
| Other Financing Activity | 1,770 | 3,052 | 24,667 | 16,333 | 8,000 |
| Financing Cash Flow | $160,407 | $28,911 | $172,131 | $132,903 | $99,765 |
| Exchange Rate Effect | -13,061 | -9,941 | 6,391 | -4,506 | 2,046 |
| Beginning Cash Position | 814,884 | 814,884 | 868,556 | 868,556 | 868,556 |
| End Cash Position | 971,193 | 684,719 | 814,884 | 1,035,210 | 659,976 |
| Net Cash Flow | $156,309 | $-130,165 | $-53,672 | $166,654 | $-208,580 |
| Free Cash Flow | |||||
| Operating Cash Flow | 42,643 | -81,515 | 104,156 | 133,951 | -225,461 |
| Capital Expenditure | -20,991 | -12,973 | -62,211 | -46,902 | -29,810 |
| Free Cash Flow | 21,652 | -94,488 | 41,945 | 87,049 | -255,271 |